<DOC>
	<DOCNO>NCT00898950</DOCNO>
	<brief_summary>This study set assess effect different dos aspirin compare placebo ( dummy drug ) , use sequentially 2 week study period 2 week wash-out ( rest period ) , people type-2 diabetes high cardiovascular risk . Specifically , effect different factor think contribute diabetes insulin resistance ( body 's ability effectively use insulin ) , dysglycaemia ( excess glucose blood ) , oxidative stress ( effect accumulation by-product metabolism ) , endothelial function ( function line blood vessel ) inflammation study .</brief_summary>
	<brief_title>Effects Different Doses Aspirin Pathophysiological Markers Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<criteria>diabetes type 2 age &gt; 18 &lt; 70 high cardiovascular risk presence active/established cardiovascular disease ( ischaemic heart disease , cerebrovascular disease peripheral vascular disease ) insulin treatment patient know peptic ulcer disease anticoagulation significant renal impairment aspirin intolerance use anticoagulant significant liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>diabetes</keyword>
	<keyword>aspirin</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>endothelial function</keyword>
	<keyword>inflammation</keyword>
	<keyword>photoplethysmography</keyword>
	<keyword>dysglycaemia</keyword>
</DOC>